SUPPLEMENTAL INFORMATION
X-ray crystallography Figure S1 . X-ray crystal structures of BDOIA383 with A) BRD4 (PDB code 5CFW) and B) CBP (PDB code 5CGP) bromodomains showing the key differences in binding interactions that contribute to the design of the more selective probe PF-CBP1 (see also Table S1 ) (related to Figure 1 ).
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A) B)
Data for PDB Code 5CFW were collected at synchrotron (Diamond, UK), and 5CGP collected in-house using a Saturn CCD detector (Rigaku, USA). Data sets were processed using XDS and scaled using Aimless. Conditions: 0.2M CaAcetate, 0.1 M Na cacodylate pH=6.6, 16% PEG 8K, 4C. Table S1 . X-ray crystallography data for BDOIA383 with BRD4 (5CFW) and CBP (5CGP) Table S2 . BRD selectivity data for PF-CBP1 (related to Figure 1 ) ATAD2B  >10  >80  BAZ2A  >10  >80  BAZ2B  >10  >80  BRD1  >10  >80  BRD2- Figure S2 . Gene expression in primary macrophages is affected by CBP BRD inhibition (related to experimental procedure 'Transcriptional profiling in primary macrophages') (n=2, gene expression normalized to Gapdh and expressed relative to media control, error bars = Standard Deviation)
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ISOX-DUAL Figure S3 . A) siRNA knock-down of CBP in primary macrophages is not efficient (related to experimental section 'CBP knock-down in primary macrophages'). Population (n = 4) Single cells (n = 164) (gene expression normalized to Gapdh and expressed relative to scrambled A)
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B)
siRNA control, error bars = SEM); B) Reduction in CBP levels results in dose-responsive reduction of cytokine gene expression (related to experimental section 'CBP knock-down in primary macrophages'). Each point represents the expression of a single cell, scored by CBP expression (x-axis) plotted versus the title gene expression (y-axis). Figure S4 . A) BET-specific targeting using iBET is a more potent inhibitor of cytokine production in macrophages (related to experimental procedure 'Transcriptional profiling in primary macrophages'); B)
Single cell expression profile of CBP-selective inhibitor PF-CBP1 is distinct from selective BET BRD inhibitor iBET (related to experimental procedure 'Transcriptional profiling in primary macrophages'); C)
Population expression profile of CBP selective compound PF-CBP1 is distinct from BET inhibitor iBET (related to experimental procedure 'Transcriptional profiling in primary macrophages') (n = 2; relative to 4 hour LPS media control; error bars = standard deviation). 
4-(2-(2-(4-((tert-butyldimethylsilyl)oxy)phenethyl)-5-(3,5-dimethylisoxazol-4-yl)-1H-benzo[d]imidazol-1-yl)ethyl)morpholine (8).
To a mixture of commercially available methyl 3-(4-hydroxyphenyl)propanoate (5, 1.53 g, 8.48 mmol) in DCM (200 mL) was added TBSCl (1.41 g, 9.33 mmol), followed by imidazole (0.85 g, 12.72 mmol) under nitrogen atmosphere. The mixture was stirred at room temperature overnight. The reaction was monitored by TLC and when the reaction was deemed complete, water (100 mL) was then added and the resulting mixture was extracted with EtOAc (200 mL) twice. The combined organic extracts were washed with brine, dried over magnesium sulfate, and filtered. The filtrates were concentrated and the crude residue was purified by flash chromatography (16~25% ethyl acetate in petroleum ether) to afford 2.2 g (88 %) of methyl 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)propanoate as colorless oil which was immediately dissolved in THF (50 mL) and carried forward in the synthetic sequence.
To the solution of methyl 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)propanoate in THF at rt was added LAH (0.46 g, 12 mmol). The resulting mixture was stirred at room temperature overnight under a nitrogen atmosphere. Additional LAH (0.2 g) was added and the reaction temperature was elevated to 30 o C until the reaction was deemed complete by TLC. Upon reaction completion, the reaction mixture was concentrated. The crude residue was dissolved into EtOAc (200 mL), and water was added carefully in portions until gas evolution ceased. The mixture was filtered, the solid washed with ethyl acetate, the filtrates were dried over sodium sulfate. The mixture was filtered and the residual solvent was evaporated to give 1.8 g of 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)propan-1-ol (90 %) as colorless liquid which was immediately taken forward in the synthetic sequence.
To a solution of 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)propan-1-ol (1.8 g, 7.2 mmol) in DCM (30 mL), was added Dess-Martin Periodinane (DMP, 3.6 g, 8.6 mmol) and the resulting mixture was stirred at room temperature for 18 h. The reaction was monitored by TLC (Petroleum ether/EtOAc = 10/1) until the reaction was deemed complete at which point the reaction mixture was filtered. The filtrates were concentrated and the crude residue was purified by flash chromatography (10~30% ethyl acetate in petroleum ether) to afford 3-(4-((tertbutyldimethylsilyl)oxy)phenyl)propanal (6, 1.6 g, 90 %) as a clear liquid which was immediately taken forward in the synthetic sequence.
To a solution of 3-(4-((tert-butyldimethylsilyl)oxy)phenyl)propanal (6, 1.45 g, 5.5 mmol) in EtOH/H 2 O (12 mL/3 mL) was added Na 2 S 2 O 4 (5.22 g, 30 mmol) and 4-(3,5-dimethylisoxazol-4-yl)-N-(2-morpholinoethyl)-2-nitroaniline (7, 3.81 g, 10.98 mmol). The mixture was allowed to stir at 80 o C for 12 hrs. The reaction was monitored by LC-MS until the reaction was deemed complete. The resulting mixture was concentrated and the crude residue was redissolved in EtOAc (50 mL) then washed with water (50 mL x 2). The combined organics were then washed with brine (50 mL), extracted, then dried over magnesium sulfate, filtered, and concentrated to give the crude residue which was then purified by silica gel flash chromatography (10~60% ethyl acetate in Petroleum ether) to give 1. 
4-(3,5-dimethylisoxazol-4-yl)-N-(2-morpholinoethyl)-2-nitroaniline (7).
Error! Bookmark not defined.
To a RB flask equipped with a stirbar and charged with 4-bromo-1-fluoro-2-nitrobenzene (37.0 g, 0.168 mol) in DMSO (450 mL) was added 1,2-aminoethylmorpholine (7b, 27.0 g, 0.208 mol) and triethylamine (21.0 g, 0.210 mol). The mixture was stirred and heated to 80 o C for 1 h. The reaction was then cooled to rt, treated with water (200 mL) and the mixture was then extracted with ethyl acetate (200 mL × 2). The combined organics were washed with water (200 mL) and brine (200 mL × 2), dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure to afford 45 g (80%) of 4-bromo-N-(2-morpholinoethyl)-2-nitroaniline (7c) as an orange solid which was carried forward in the synthetic sequence without any further purification or characterization.
To a RB flask charged with 4-bromo-N-(2-morpholinoethyl)-2-nitroaniline (7c, 33.4 g, 97.0 mmol), (3,5-dimethylisoxazol-4-yl)boronic acid (7d, 15.4 g, 109 mmol), PdCl 2 (dppf)CH 2 Cl 2 (4.1 g, 5 mmol) and Cs 2 CO 3 (82 g, 250 mmol) was added p-dioxane (1 L) at rt. The resulting mixture was sparged with argon for 10 minutes, then the reaction mixture was heated to 100 o C and stirred at this temperature for 20 h. The mixture was then cooled to rt and filtered through a pad of celite using ethyl acetate to rinse the filter cake. The filtrates were collected and concentrated and the crude residue was purified by flash chromatography (10-50% ethyl acetate in petroleum ether) to provide 21 g (62 %) of the titled compound (7) -3,5-dimethyl-N-(2-morpholinoethyl)-2-nitroaniline (20) . To a RB flask charged with 2-bromo-5-fluoro-1,3-dimethyl-4-nitrobenzene (18, 500 mg, 2.0 mmol) and 1,2-aminethylmorpholine (19, 320 mg, 2.4 mmol) was added triethylamine (500 mg, 5 mmol) in DMSO (10 mL). The mixture was then heated to 80 o C and stirred for 3 h. The reaction mixture was then cooled to rt and combined with water (50 mL). The precipitated solid was collected by filtration and dried under reduced pressure to afford 0.8 g (99%) of the titled compound (20) as a red solid used in the next step without further purification or characterization. , PdCl 2 (dppf), (7 mg, 0.01 mmol), and Cs 2 CO 3 (160 mg, 0.5 mmol) was added p-dioxane (2 mL) and the mixture was sparged with argon for 10 minutes. The vessel was then sealed and placed in a microwave reactor which was heated to 100 o C for 3 h at 300W power. The reaction mixture was then cooled to rt and diluted with EtOAc (20 mL). The organic phase was washed with brine (50 mL), dried over Na 2 SO 4 , filtered, and concentrated under reduced pressure. The crude residue was then purified by silica gel flash chromatography 
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